[Form 4] Children's Place, Inc. Insider Trading Activity

Rhea-AI Filing Summary

John Szczepanski, Chief Financial Officer of The Childrens Place, Inc. (PLCE), was granted 100,000 restricted stock units on August 20, 2025. The awards represent shares of common stock subject to the Companys 2011 Equity Incentive Plan and are deliverable one-third on May 28, 2027, May 30, 2028 and May 25, 2029, provided Mr. Szczepanski remains employed on those dates. The grant was authorized July 8, 2025 and was issued based on the closing price of $5.00 on that authorization date; the restricted stock unit agreements were finalized on August 20, 2025. The Form 4 reports 100,000 shares beneficially owned following the transaction and is signed by an attorney-in-fact on behalf of Mr. Szczepanski.

Positive

• 100,000 restricted stock units granted to the CFO, documented on Form 4
• Clear multi-year vesting schedule: one-third vesting on May 28, 2027, May 30, 2028 and May 25, 2029
• Grant authorized July 8, 2025 and priced based on a closing share price of $5.00

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO received a 100,000-RSU award with multi-year vesting; a routine compensation grant with limited immediate market impact.

The filing documents a time-based equity grant to the companys Chief Financial Officer totaling 100,000 restricted stock units, vesting in three equal tranches in 2027, 2028 and 2029. The grant was authorized July 8, 2025 using a $5.00 closing price and finalized August 20, 2025. From an analysts perspective, this is a conventional retention and compensation mechanism; the Form 4 shows the resultant beneficial ownership but does not disclose acceleration, performance metrics, or additional cash considerations.

Corporate Governance Expert

TL;DR: Document records a standard executive equity award with explicit time-based vesting tied to continued employment.

The disclosure clearly states the awards are restricted stock units granted under the 2011 Equity Incentive Plan and vest one-third on specified dates contingent on employment. The Form 4 provides appropriate details: grant date, authorization date, stock price used for grant pricing, and post-transaction beneficial ownership. The filing is procedural and contains no indication of unusual governance provisions or immediate transfer of shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Szczepanski John

(Last) (First) (Middle)

C/O THE CHILDREN'S PLACE, INC.

500 PLAZA DRIVE

(Street)

SECAUCUS NJ 07094

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Childrens Place, Inc. [ PLCE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.10 per share	08/20/2025		A		100,000(1)	A	$0	100,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Common Stock, par value $0.10 per share, of The Children's Place, Inc. (the "Company"), underlying restricted stock units granted under the Company's 2011 Equity Incentive Plan (the "Plan") on August 20, 2025, one third of which may be deliverable to Mr. Szczepanski on May 28, 2027, May 30, 2028 and May 25, 2029, provided Mr. Szczepanski is employed by the Company on the respective vesting dates, subject to the terms and conditions of the Plan. The Company authorized the grant of the underlying shares on July 8, 2025 and as a result, these shares are granted based on the closing stock price of $5.00 on that date, subject to the finalization of the restricted stock unit agreements which occurred on August 20, 2025.

	/s/ Jared Shure, as Attorney-In-Fact for John Szczepanski	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PLCE report for John Szczepanski?

The Form 4 reports a grant of 100,000 restricted stock units to John Szczepanski, CFO, on August 20, 2025.

When do the restricted stock units granted to PLCE's CFO vest?

The RSUs vest in three equal tranches: May 28, 2027, May 30, 2028, and May 25, 2029, contingent on continued employment.

What price was used to determine the RSU grant to John Szczepanski?

The grant was authorized on July 8, 2025 and was based on the closing stock price of $5.00 on that date.

How many shares does John Szczepanski beneficially own after the reported transaction?

The Form 4 reports 100,000 shares of common stock beneficially owned following the transaction.

Who signed the Form 4 on behalf of John Szczepanski?

The filing was signed by Jared Shure, as Attorney-In-Fact for John Szczepanski on August 22, 2025.